Mindstate Design Labs · Dec 2025
Company press release announcing Graeme Bell as an independent board director; also reiterates the Osmanthus platform and provides a public contact email.
Clinical-stage AI neuroengineering platform
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Clinical-stage AI neuroengineering and drug development company building programmable psychoactive therapeutics for mental health. Primary product is the Osmanthus platform and lead asset MSD-001, which map subjective trip-report data to receptor biology to design specific emotional and cognitive states.
Primary product
Osmanthus platform and lead asset MSD-001
Founded
2021
Headquarters
South San Francisco, California, United States
Team size
11-50
Work style
Remote
Industry
Biotechnology
Sub-industry
Clinical-stage neuroengineering / psychedelic therapeutics
Offices
South San Francisco, California, United States
Pittsburgh, Pennsylvania, United States
Business model
Drug discovery
Clinical development
Potential pharma partnering / licensing
Funding
Stage
Seed / early-stage
Total raised
$24.3M
Latest round
Undisclosed · Nov 2024
Latest amount
$12.7M
Nov 2024
Feb 2022 · Initialized Capital
Sep 2021 · Y Combinator
People & investors
Leadership
Co-Founder & CEO
Scientific Co-Founder
Chief Scientific Officer
Head of Preclinical Development
Medical Director
Jianhong Wang, PhD
Head of DMPK
Jessica Smith Beaver, PhD, MLS
Head of Regulatory Affairs
Senior Director of Operations
Head of Clinical Operations
Head of Drug Product & Formulation
Michael Hoyos
Head of Business Development
Independent Board Director
Investors
10X Capital
Actions Capital
Apoorva Mehta
Ayuh Ventures
Blast.club
Cursive Holdings
Day One Ventures
Empath Ventures
Fred Ehrsam
Hub Angels Investment Group
Immeasurable
Initialized Capital
Innovating Capital
K50 Ventures
Lionheart Ventures
Max Hodak
Metaplanet Holdings
Mystic Ventures
Naval Ravikant
Negev Capital
One Mind Accelerator
Page One Ventures
Rand Hindi
Y Combinator
Work & culture
Mission-driven, research-heavy, and expert-led; public materials emphasize a top-tier team, remote-first operation, and building novel therapeutics in a fast-moving clinical-stage setting.
Work style
Remote
Compensation
Public job posting describes compensation as competitive and paired with full health coverage and a remote-first setup.
Benefits
Full health insurance premiums covered
Complete tech setup for remote work
Remote-first setup
Competitive compensation
Product & market
Pricing
Not publicly disclosed; primarily drug-development and potential partnering/licensing economics.
Differentiators
- —Osmanthus uses AI to synthesize subjective trip reports with biochemical data
- —Focuses on designing psychoactive states rather than only single molecules
- —Lead program aims for emotional and cognitive flexibility without hallucinations
- —Uses a primer/probe approach to engineer specific effects
- —Clinical-stage human studies already underway
Technology
multi-agent LLMs
large language models
natural language processing
frontier/custom embedding models
Bayesian neural networks
machine learning
biochemical data synthesis
receptor-activity mapping
Competitors
MindMed
Compass Pathways
Beckley Psytech
Alto Neuroscience
Filament Health
Helus Pharma
VCENNA
Biomind Labs
Scale & contact
Estimated revenue
about $1M annually
Latest news
Mindstate Design Labs · Sep 2025
Official announcement of topline MSD-001 study results and the lead fixed-dose combination program.
Fierce Biotech · Mar 2024
Reports that Mindstate submitted its first IND for MSD-001 and outlined its AI-driven approach to designing psychoactive states.
Technical.ly · Feb 2022
Adds Pittsburgh context and confirms the seed round and company mission in psychedelic-inspired therapeutics.
Business Insider · Feb 2022
Covers the $11.5M seed round led by Initialized Capital and participation from a group of venture and angel investors.
Jobs and careers at Mindstate Design Labs
1 job at Mindstate Design Labs
Open Application
Remote
Future Opportunities
Remote (United States)
7mo ago
Remote
Full-time